InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Friday, 03/16/2018 1:14:10 PM

Friday, March 16, 2018 1:14:10 PM

Post# of 38634
My take on the offering is it will be used to pay for Rexista HAP studies and day to day expenses for the next couple of months. My hope is it is enough to fund PODRAS first clinical human trials as well. I also believe Regabatin will not go anywhere until a partner is found. I think I heard at one point the PH3 trials on Regabatin would cost about $10-20M.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y